Table 5.
Mature sizea | Implantb | Pooled | |||||
---|---|---|---|---|---|---|---|
Item | SMS | LMS | P value | SS | CH | P value | SEM |
n, steers | 63 | 60 | – | 61 | 62 | – | – |
n, pens | 8 | 8 | – | 8 | 8 | – | – |
HCW, kg | 346 | 403 | <0.01 | 377 | 372 | 0.12 | 2.0 |
Dressc, % | 61.47 | 61.95 | 0.14 | 61.86 | 61.56 | 0.32 | 0.205 |
Back fat thickness, cm | 1.20 | 1.31 | 0.10 | 1.27 | 1.24 | 0.67 | 0.041 |
LMA, cm2 | 79.84 | 85.64 | 0.01 | 83.33 | 82.16 | 0.48 | 1.129 |
LMA/HCW, 6.45 cm2/45.4 kg | 1.63 | 1.50 | <0.01 | 1.56 | 1.56 | 0.96 | 0.018 |
Calculated yield grade | 3.05 | 3.32 | 0.02 | 3.18 | 3.19 | 0.96 | 0.067 |
Marbling scored | 563 | 569 | 0.69 | 556 | 576 | 0.18 | 9.8 |
Kidney pelvic heart fat | 2.14 | 2.01 | 0.18 | 2.03 | 2.11 | 0.41 | 0.064 |
Quality grade | |||||||
Prime, % | 0.00 | 0.00 | – | 0.00 | 0.00 | – | – |
High choice, % | 1.68 | 3.17 | 0.59 | 0.00 | 4.87 | 0.08 | 1.990 |
Average choice, % | 22.04 | 26.76 | 0.55 | 26.17 | 22.62 | 0.65 | 5.616 |
Low choice, % | 65.17 | 51.42 | 0.13 | 55.40 | 61.18 | 0.52 | 6.384 |
Select, % | 11.11 | 18.65 | 0.24 | 18.43 | 11.33 | 0.27 | 4.589 |
EBFe, % | 29.34 | 30.61 | 0.01 | 29.97 | 29.98 | 0.98 | 0.259 |
AFBWe,f, kg | 526 | 590 | <0.01 | 562 | 554 | 0.19 | 3.6 |
EQSBWg, kg | 270 | 301 | <0.01 | - | - | - | 2.0 |
Calculated FSh | 4.75 | 6.74 | <0.01 | 5.87 | 5.62 | 0.18 | 0.117 |
aSMS, smaller mature size; LMS, larger mature size.
bSS, implanted with 20 mg estradiol benzoate and 200 mg progesterone on d 1 and with 24 mg estradiol and 120 mg trenbolone acetate on d 85; CH, implanted with 14 mg estradiol benzoate and 100 mg trenbolone acetate on d 1 and with 24 mg estradiol and 120 mg trenbolone acetate on d 85.
cCalculated as HCW divided by final body weight.
dSmall0, 500, Modest0, 600.
eEstimated using equations of Guiroy et al. (2001).
fAFBW, final shrunk weight at 28% empty body fat.
gEQSBW, equivalent shrunk body weight (Tylutki et al., 1994).
hEstimated using final shrunk weight at 28% EBF and data from Fox et al. (1992).